Organocatalysis in heterocyclic synthesis: DABCO as a mild and efficient catalytic system for the synthesis of a novel class of quinazoline, thiazolo [3,2-a]quinazoline and thiazolo[2,3-b] quinazoline derivatives

Chemistry Central Journal

Volumn 7, Issue 1, 2013, Pages

  Behbehani, Haider ^a   Ibrahim, Hamada Mohamed ^a,b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Fayoum University   (Egypt)

Author keywords

DABCO; Organocatalysis; Quinazoline; Thiazolo 2,3 b quinazoline; Thiazolo 3,2 a quinazoline

Indexed keywords

EID: 84877040484     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-7-82     Document Type: Article

References (56)

1. Wu J, Sun X, Li Y. DABCO: An efficient organocatalyst in the ring-opening reactions of aziridines with amines or thiols. Eur J Org Chem 2005, 20:4271-4275.
2. Yamguchi K, Eto M, Higashi K, Yoshitake Y, Harano K. DABCO-triggered mild cascade reaction of electron-eficient cyclopentadienone: facile and efficient synthesis of condensed carbocycles. Tetrahedron Lett 2011, 52:6082-6085.
3. Wu J-W, Li F, Zheng Y, Nie J. DABCO-mediated one-pot sequential transformation: convenient access to fluorinated 1H-pyrazol-5(4H)-ones. Tetrahedron Lett 2012, 53:4828-4831.
4. Palomo C, Oiarbide M, Mielgo A. Unveiling reliable catalysts for the asymmetric nitroaldol (Henry) reaction. Angew Chem Int Ed 2004, 43:5442-5444.
5. Wang R, Yue L, Pan W, Zhao J-J. Direct transition metal-free C-S bond formation: synthesis of 2-aminobenzothiazole derivatives via base-mediated approach. Tetrahedron Lett 2012, 53:4529-4531.
6. Abdel Gawad NM, Georgey HH, Youssef RM, El-Sayed NA. Synthesis and antitumor activity of some 2,3-disubstituted quinazolin-4(3H)-ones and 4,6-disubstituted-1,2,3,4-tetrahydro- quinazolin-2H-ones. Eur J Med Chem 2010, 45:6058-6067. 10.1016/j.ejmech.2010.10.008, 21051122.
7. Chandrika PM, Yakaiah T, Rao AR, Narsaiah B, Reddy NC, Sridhar V, Rao JV. Synthesis of novel 4,6-disubstituted uinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. Eur J Med Chem 2008, 43:846-852. 10.1016/j.ejmech.2007.06.010, 17689837.
8. Al-Omary FAM, Hassan GS, El-Messery SM, El-Subbagh HI. Substituted thiazoles V. Synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]- pyrimidine analogues. Eur J Med Chem 2012, 47:65-72.
9. Marvania B, Lee P-C, Chaniyara R, Dong H, Suman S, Kakadiya R, Chou T-C, Lee T-C, Shah A, Su T-L. Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates. Bioorg Med Chem 2011, 19:1987-1998. 10.1016/j.bmc.2011.01.055, 21356592.
10. Decker M, Kraus B. Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties. Bioorg Med Chem 2008, 16:4252-4261. 10.1016/j.bmc.2008.02.083, 18343673.
11. El-Gazzar ABA, Youssef MM, Youssef AMS, Abu-Hashem AA, Badria FA. Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflamm- atory and analgesic activities. Eur J Med Chem 2009, 44:609-624. 10.1016/j.ejmech.2008.03.022, 18462840.
12. Kumar A, Sharma S, Bajaj AK, Sharma S, Panwar H, Singh T, Srivastava VK. Some new 2,3,6-trisubstituted quinazolinones as potent anti-inflammatory, analgesic and COX-II inhibitors. Bioorg Med Chem 2003, 11:5293-5299. 10.1016/S0968-0896(03)00501-7, 14604693.
13. Aly MM, Mohamed YA, El-Bayouki KM, Basyouni WM, Abbas SY. Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities. Eur J Med Chem 2010, 45:3365-3373. 10.1016/j.ejmech.2010.04.020, 20510483.
14. Pandeya SN, Sriram D, Nath G, Clercq ED. Synthesis antibacterial antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one. Pharm Acta Helv 1999, 74:11-17. 10.1016/S0031-6865(99)00010-2, 10748620.
15. Selvam P, Girija K, Nagarajan G, De Clerco E. Synthesis, antibacterial, and anti-HIV activities of 3-[5-amino-6-(2,3-dichlorophenyl)-[1,2,4]triazin-3-yl]-6,8-dibromo-2-substituted-3H-quin- azolin-4-one. Indian J Pharm Sci 2005, 67:484-487.
16. Ghorab MM, Abdel-Gawad SM, El-Gaby MSA. Synthesis and evaluation of some new fluorinated hydroquinazoline derivatives as antifungal agents. II Farmaco 2000, 55:249-255.
17. Cakici M, Catir M, Karabuga S, Kilic H, Ulukanli S, Gulluce M, Orhan F. Synthesis and biological evaluation of (S)-4-aminoquinazoline alcohols. Tetrahedron-Asymmetr 2010, 21:2027-2031.
18. Alagarsamy V, Pathak US. Synthesis and antihypertensive activity of novel 3-benzyl-2-substituted-3H-[1,2,4]triazolo[5,1-b]quinazolin-9-ones. Bioorg Med Chem 2007, 15:3457-3462. 10.1016/j.bmc.2007.03.007, 17391966.
19. Agarwal KC, Sharma V, Shakya N, Gupta S. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents. Bioorg Med Chem Lett 2009, 19:5474-5477. 10.1016/j.bmcl.2009.07.081, 19692240.
20. Kashawa SK, Kashawa V, Mishra P, Jain NK, Stables JP. Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2- phenyl/ethyl-4H-quinazolin-3-yl)urea. Eur J Med Chem 2009, 44:4335-4343. 10.1016/j.ejmech.2009.05.008, 19674817.
21. Liesen AP, Aquino TM, Carvalho CS, Lima VT, Araujo JM, Lima JG, Faria AR, Melo EJT, Alves AJ, Alves EW, Alves AQ, Goes AJS. Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles. Eur J Med Chem 2010, 45:3685-3691. 10.1016/j.ejmech.2010.05.017, 20541294.
22. Omar K, Geronikaki A, Zoumpoulakis P, Camoutsis C, Sokovic M, Ciric A, Glamoclija J. Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs. Bioorg Med Chem 2010, 18:426-432. 10.1016/j.bmc.2009.10.041, 19914077.
23. Liu X, Zheng C, Sun L, Liu X, Piao H. Synthesis of new chalcone derivatives bearing 2,4-thiazolidinedione and benzoic acid moieties as potential anti-bacterial agents. Eur J Med Chem 2011, 46:3469-3473. 10.1016/j.ejmech.2011.05.012, 21624712.
24. Upadhyay A, Srivastava SK, Srivastava SD. Conventional and microwave assisted synthesis of some new N-[(4-oxo-2-substituted aryl-1,3-thiazolidine)acetamidyl]-5-nitroindazoles and its antimicrobial activity. Eur J Med Chem 2010, 45:3541-3548. 10.1016/j.ejmech.2010.04.029, 20570024.
25. Vintonyak VK, Warburg K, Kruse H, Grimme S, Hubel K, Rauh D, Waldmann H. Indentification of thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of the mycobacterium tuberculosis protein tyrosine phosphatase B. Angew Chem 2010, 122:6038-6041.
26. Wang S, Zhao Y, Zhang G, Lv Y, Zhang N, Gong P. Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent. Eur J Med Chem 2011, 46:3509-3518. 10.1016/j.ejmech.2011.05.017, 21621880.
27. Lv P, Zhou C, Chen J, Liu P, Wang K, Mao W, Li H, Yang Y, Xiong J, Zhu H. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. Bioorg Med Chem 2010, 18:314-319. 10.1016/j.bmc.2009.10.051, 19914835.
28. Havrylyuk D, Mosula L, Zimenkovsky B, Vasylenko O, Gzella A, Lesyk R. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur J Med Chem 2010, 45:5012-5021. 10.1016/j.ejmech.2010.08.008, 20810193.
29. Maccari R, Corso AD, Giglio M, Moschini R, Mura U, Ottana R. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. Bioorg Med Chem Lett 2011, 21:200-203. 10.1016/j.bmcl.2010.11.041, 21129963.
30. Rawal RK, Tripathi R, Katti SB, Pannecouque C, De Clercq E. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents. Eur J Med Chem 2008, 43:2800-2806. 10.1016/j.ejmech.2007.12.015, 18242784.
31. Mobinikhaledi A, Foroughifar N, Ebrahimi S, Rahimi F, Zandi F. Synthesis of some novel 2-aryl- idene thiazoloquinazolinone derivatives via one-pot, three-component reaction. Phosphorus Sulfur Silicon Relat Elem 2011, 186:457-463.
32. Feng Y, Ding X, Chen T, Chen L, Liu F, Jia X, Luo X, Shen X, Chen K, Jiang H, Wang H, Liu H, Liu D. Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors. J Med Chem 2010, 53:3465-3479. 10.1021/jm901004c, 20405848.
33. Bouillon I, Krchnak V. Efficient solid-phase synthesis of 3-substituted-5-Oxo-5H-thiazolo[2,3-b]quinazoline-8-carboxamides under mild conditions with two diversity positions. J Comb Chem 2007, 9:912-915. 10.1021/cc700122a, 2569825, 17907790.
34. Loge C, Testard A, Thierry V, Lozach O, Blairvacq M, Robert J-M, Meijer L, Besson T. Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies. Eur J Med Chem 2008, 43:1469-1477. 10.1016/j.ejmech.2007.09.020, 17981370.
35. Testard A, Loge C, Leger B, Robert J-M, Lozach O, Blairvacq M, Meijer L, Thiery V, Besson T. Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3. Bioorg Med Chem Lett 2006, 16:3419-3423. 10.1016/j.bmcl.2006.04.006, 16644220.
36. McIntyre NA, McInnes C, Griffiths G, Barnett AL, Kontopidis G, Slawin AMZ, Jackson W, Thomas M, Zheleva DI, Wang S, Blake DG, Westwood NJ, Fischer PM. Design, synthesis, and evaluation of 2-methyl- and 2-amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines as ring-constrained 2-anilino-4-(thiazol-5-yl)pyrimidine cyclin-dependent kinase inhibitors. J Med Chem 2010, 53:2136-2145. 10.1021/jm901660c, 20146435.
37. Mrkvicka V, Klasek A, Kimmel R, Pevee A, Kosmrlj J. Thermal reaction of 3aH,5H-thiazolo[5,4-c]quinoline-2,4-diones an easy pathway to 4-amino-1H-quinoline-2-ones and novel 6H-thiazolo[3,4-c]quinazoline-3,5-diones. ARKIVOC 2008, 14:289-302.
38. Grasso S, Micale N, Monforte A-M, Monforte P, Polimeni S, Zappala M. Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]quinazolines. Eur J Med Chem 2000, 35:1115-1119. 10.1016/S0223-5234(00)01195-8, 11248410.
39. Bakherad M, Keivanloo A, Kalantar Z, Keley V. Regioselective syntheses of 1-aryl-substituted-5H-[1,3]thiazolo[3,2-a]quinazoline-5-ones during Sonogashira coupling. Phosphorus Sulfur Silicon Relat Elem 2011, 186:464-470.
40. Jain KK, Rout SP, Pujari HK. Heterocyclic systems containing bridgehead nitrogen atom. Part LXIV. Synthesis of 7-methylthiazolo[3,2-a]quinazolines. Indian J Chem Sect B 1990, 29B:379-80.
41. Behbehani H, Ibrahim HM, Makhseed S, Mahmoud H. Applications of 2-arylhydrazononitriles in synthesis: preparation of new indole containing 1,2,3-triazole, pyrazole and pyrazolo[1,5-a]pyrimidine derivatives and evaluation of their antimicrobial activities. Eur J Med Chem 2011, 46:1813-1820. 10.1016/j.ejmech.2011.02.040, 21397366.
42. Behbehani H, Ibrahim HM, Makhseed S, Elnagdi MH, Mahmoud H. 2-Aminothiophenes as building blocks in heterocyclic synthesis: synthesis and antimicrobial evaluation of a new class of pyrido[1,2-a]thieno[3,2-e]pyrimidine, quinoline and pyridin-2-one derivatives. Eur J Med Chem 2012, 52:61-65.
43. Behbehani H, Ibrahim HM. 4-Thiazolidinones in heterocyclic synthesis: synthesis of novel enaminones, azolopyrimidines and 2-Arylimino-5-arylidene-4-thiazolidinones. Molecules 2012, 17:6362-6385. 10.3390/molecules17066362, 22634845.
44. Vicini P, Geronikaki A, Anastasia K, Incerti M, Zani F. Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones. Bioorg Med Chem 2006, 14:3859-3864. 10.1016/j.bmc.2006.01.043, 16488614.
45. Gruner M, Rehwald M, Eckert K, Gewald K. New synthesis of 2-alkylthio-4-oxo-3,4-dihydroquinazolines, 2-alkylthioquinazolines, as well as, their hetero analogues. Heterocycles 2000, 53:2363-2377.
46. Crystallographic data for 3 (ref. CCDC 916675) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
47. Crystallographic data for 4 (ref. CCDC 916665) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
48. Crystallographic data for 5 (ref. CCDC 916666) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
49. Crystallographic data for 9a (ref. CCDC 916667) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
50. Crystallographic data for 9c (ref. CCDC 916674) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
51. Crystallographic data for 9d (ref. CCDC 916671) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
52. Crystallographic data for 9f (ref. CCDC 916670) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
53. Crystallographic data for 9h (ref. CCDC 916673) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
54. Crystallographic data for 10 (ref. CCDC 916672) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
55. Crystallographic data for 12 (ref. CCDC 916668) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.
56. Crystallographic data for 13 (ref. CCDC 916669) can be obtained on request from the director 12 Union Road, Cambridge CB2 1EW, UK: Cambridge Crystallographic Data Center.